EP. 10: HER2-Positive Breast Cancer: Special Challenges and Expert Insight
June 15th 2021
This article discusses recent developments in HER2-targeted therapies and new challenges for clinicians treating patients with HER2-positive breast cancer, and includes expert insights from Adam M. Brufsky, MD, PhD, of the University of Pittsburgh Medical Center in Pittsburgh, PA, V.K. Gadi, MD, PhD, of the University of Illinois in Chicago, IL, and Sara A. Hurvitz, MD, of the David Geffen School of Medicine at the University of California Los Angeles, in Los Angeles, CA, and Neil M. Iyengar, MD, of Memorial Sloan Kettering Cancer Center in New York, NY.